📊 Score Breakdown
Offering Ability
20
Cash Runway
0
Float Risk
25
Warrant Exposure
50
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
27%
🔁 Convertible Conversion
40%
• Significant convertible debt: 17% potential dilution
• Elevated convertible risk (60/100)
📜 Warrant Exercise
15%
• Warrant overhang: 11.5% of shares outstanding
📉 Score Deterioration
15%
• Score climbed 6 points (worsening)
💹 Market Data
Market Cap$2.65B
Shares Outstanding24.29M
Float23.39M
Cash$142.24M
Debt$1.24B
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 2.0% shares (2025Q4 vs prior)
333 institutional holders · 27.39M shares
#1
BlackRock, Inc.
3.54M shares
#2
VANGUARD GROUP INC
2.67M shares
#3
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC
2.00M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest1.89M
Days to Cover4.8
% of Float8.1%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL CONVERTIBLE
Dec 31, 2025
xbrl
XBRL WARRANT
Dec 31, 2025
4
INSIDER TRANSACTION
Apr 01, 2026
3
FORM3
Mar 31, 2026
4
INSIDER TRANSACTION
Mar 31, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for LCII
📊 LCII FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 LCII Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.